Level Four Advisory Services’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
CFM
GS
Level Four Advisory Services's ATNM Position: Q2 2026 in Review
Level Four Advisory Services sold out of Actinium Pharmaceuticals (ATNM) in Q2 2026, closing a stake of 10,000 shares — an estimated $9.95K sold.
Level Four Advisory Services first reported a position in ATNM in Q3 2025 and held it in 3 quarters. The position peaked at $16K in Q3 2025. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.
- Level Four Advisory Services reported no remaining Actinium Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Level Four Advisory Services sold 10,000 Actinium Pharmaceuticals shares in Q2 2026, an estimated $9.95K.
- Level Four Advisory Services first reported a position in Actinium Pharmaceuticals in Q3 2025 and held it in 3 quarters.
- Level Four Advisory Services's Actinium Pharmaceuticals position peaked at $16K in Q3 2025.
- 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.